Anti-RIP3 (phospho T231 + S232) 抗体 [2D7]
Anti-RIP3 (phospho T231 + S232) antibody [2D7]
0
(1 Review)
|
(24 Publications)
Mouse Monoclonal RIP3 phospho S232 + T231 antibody. Suitable for ELISA, WB and reacts with Synthetic peptide, Mouse samples. Cited in 24 publications.
別名を表示する
Rip3, Ripk3, Receptor-interacting serine/threonine-protein kinase 3, RIP-like protein kinase 3, Receptor-interacting protein 3, RIP-3, mRIP3
- WB
Supplier Data
Western blot - Anti-RIP3 (phospho T231 + S232) antibody [2D7] (AB205421)
Blocking and diluting buffer concentration : 5% NFDM/TBTS.
ab181602 was used as a loading control at 1/1000000 dilution.
We recommend involving downstream protein p-MLKL as a control to validate the stimulation of p-RIP3.
Lanes 1 - 4:
Western blot - Anti-RIP3 (phospho T231 + S232) antibody [2D7] (ab205421) at 1/1000 dilution
Lanes 5 - 8:
Western blot - Anti-MLKL (phospho S345) antibody [EPR9515(2)] (<a href='/products/primary-antibodies/mlkl-phospho-s345-antibody-epr95152-ab196436'>ab196436</a>) at 1/1000 dilution
Lanes 1, 3, 5 and 7:
Untreated L-929 (mouse connective tissue fibroblast cell line) whole cell lysate at 20 µg
Lanes 2 and 6:
L-929 (mouse connective tissue fibroblast cell line) treated with 20 ng/ml TNF-a, 100 nM Smac mimetic and 20 μM z-VAD for 8 hours whole cell lysate at 20 µg
Lanes 4 and 8:
L-929 (mouse connective tissue fibroblast cell line) treated with 20 ng/ml TNF-a, 100 nM Smac mimetic and 20 μM z-VAD for 6 hours whole cell lysate at 20 µg
Secondary
Lanes 1 - 4:
Peroxidase-Conjugated Goat anti-Mouse IgG (H+L) at 1/20000 dilution
Lanes 5 - 8:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 57 kDa,54 kDa
Observed band size: 53 kDa
false
Exposure time: 180s
- WB
Lab
Western blot - Anti-RIP3 (phospho T231 + S232) antibody [2D7] (AB205421)
Blocking buffer : 2% BSA.
Performed under reducing conditions.
All lanes:
Western blot - Anti-RIP3 (phospho T231 + S232) antibody [2D7] (ab205421) at 1 µg/mL
Lane 1:
Mouse Pancreas Tissue Lysate at 10 µg
Lane 2:
Mouse Kidney Tissue Lysate at 20 µg
Lane 3:
Mouse Small Intestine Tissue Lysate at 20 µg
Secondary
All lanes:
Goat polyclonal to Mouse IgG - H&L - Pre-Adsorbed (HRP) at 1/5000 dilution
Predicted band size: 57 kDa
Observed band size: 57 kDa
false
Exposure time: 4min
- ELISA
Lab
ELISA - Anti-RIP3 (phospho T231 + S232) antibody [2D7] (AB205421)
Serially diluted ab205421 was bound to immobilised RIP3 phospho peptide (T231), RIP3 phospho peptide (S232), RIP3 dual phospho peptide (T231+S232) or RIP3 control peptide (RIP3-nP; all peptides at 1 microgram x mL-1). The antibody was detected by HRP-labeled goat anti-mouse IgG and signal was developed with TMB substrate.
Reactivity data
製品の詳細
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
RIP3 facilitates the execution of necroptosis a form of programmed cell death distinct from apoptosis. It becomes activated upon binding with RIP1 forming a necrosome complex that is essential for this pathway. This complex promotes phosphorylation events that subsequently lead to membrane rupture and cell death. Apart from its role in necroptosis RIP3 also engages in metabolic regulation processes linking energy status and cell death under conditions of stress.
Pathways
RIP3 is a principal component of the necroptotic pathway interacting closely with RIP1 to trigger cell death in conditions where caspase activation is inhibited. Alternatively it integrates into metabolic pathways participating in sensing and responding to changes in cellular energy states. The interplay between RIP3 and RIP1 within these pathways illustrates their shared involvement in maintaining cellular homeostasis and triggering cell death when necessary.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (24)
Recent publications for all applications. Explore the full list and refine your search
PLoS pathogens 21:e1013167 PubMed40359428
2025
Applications
Unspecified application
Species
Unspecified reactive species
eLife 13: PubMed40132021
2025
Applications
Unspecified application
Species
Unspecified reactive species
Chinese medical journal pulmonary and critical care medicine 2:265-278 PubMed39834583
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell & bioscience 14:55 PubMed38678262
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 15:133 PubMed38168040
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 14:432 PubMed37454215
2023
Applications
Unspecified application
Species
Unspecified reactive species
Redox biology 62:102687 PubMed36989574
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 13:6891 PubMed36371441
2022
Applications
Unspecified application
Species
Unspecified reactive species
STAR protocols 3:101517 PubMed35779260
2022
Applications
Unspecified application
Species
Unspecified reactive species
Lupus science & medicine 9: PubMed35414608
2022
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com